Daejeon, South Korea

Sei Ryang Oh

USPTO Granted Patents = 23 


 

Average Co-Inventor Count = 9.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: Sei Ryang Oh: Innovator in Pharmaceutical Compositions

Introduction

Sei Ryang Oh, based in Daejeon, South Korea, is a notable inventor with an impressive portfolio of 22 patents. His work primarily focuses on pharmaceutical compositions that aim to prevent and treat respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma.

Latest Patents

Among his latest innovations, Oh has developed a pharmaceutical composition that comprises an extract, fraction, or compound isolated for preventing or treating COPD. This novel composition is designed to suppress the invasion of inflammatory cells into the bronchial tubes, along with effectively reducing the expression of pro-inflammatory markers like CXCL-1, TNF-α, and MIP-2. By utilizing a safety-proven herbal drug, his formulation addresses the side effects of existing treatments for COPD while providing an effective remedy for related conditions such as chronic bronchitis and acute inflammation.

Another significant patent by Oh pertains to a composition for preventing or treating asthma, which incorporates the extract of J. Poiss. ex Franch. This invention demonstrates a non-toxic profile and is proven to inhibit the generation of various inflammatory cytokines and reactive oxygen species. The patented composition effectively alleviates airway hyperresponsiveness and inflammation in a mouse model of asthma, representing a promising avenue for safer therapeutic options.

Career Highlights

Sei Ryang Oh has made substantial contributions to the field of bioscience and biotechnology during his tenure at prominent institutions such as the Korea Research Institute of Bioscience and Biotechnology and Enzychem Lifesciences Corporation. His innovative research has opened new pathways for treating respiratory disorders and enhancing patient outcomes.

Collaborations

Throughout his career, Oh has collaborated with notable colleagues, including Kyung Seop Ahn and Hyeong Kyu Lee. Their collective efforts have likely contributed to the development of impactful innovations within the realm of pharmaceutical sciences.

Conclusion

Sei Ryang Oh exemplifies the pivotal role of inventors in advancing healthcare solutions. His innovative approaches to developing pharmaceutical compositions for preventing and treating respiratory diseases underscore the importance of ongoing research and collaboration in the field, ultimately aiming to improve therapeutic options and quality of life for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…